✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

CanSino Biologics Inc

Common Name
CanSino Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,134
Ticker
688185
Exchange
Shanghai Stock Exchange
Description
CanSino Biologics Inc. is a biotechnology company focused on developing, manufacturing, and commercializing high-quality vaccines for public health. Founded in Tianjin, China, the company is known for...

CanSino Biologics's Revenues Data

Explore CanSino Biologics's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
151,323,696a
113,027,222a
48,569,299b
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind CanSino Biologics’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. CanSino Biologics's Annual Report 2025
b. CanSino Biologics's Annual Report 2024